Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

238.68
Delayed Data
As of Sep 26
 -5.26 / -2.16%
Today’s Change
195.50
Today|||52-Week Range
322.68
-23.62%
Year-to-Date
Ruane Cunniff Cuts Allergan, Berkshire, IBM
Sep 26 / GuruFocus News - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
Sep 26 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and G...
Sep 26 / Zacks.com - Paid Partner Content
ETFs in Focus on the Nasdaq Rally
Sep 23 / Zacks.com - Paid Partner Content
Allergan Gets FDA Approval for New Line of Breast Implants
Sep 26 / Zacks.com - Paid Partner Content
Allergan/Adamas Launch New Dosage Strengths of Namzaric
Sep 23 / Zacks.com - Paid Partner Content
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
Sep 26 / Zacks.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close243.94
Today’s open242.20
Day’s range238.27 - 242.62
Volume2,501,684
Average volume (3 months)3,156,331
Market cap$96.6B
Dividend yield--
Data as of 4:00pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.95%
Earnings growth (next 5 years)+13.53%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.31-0.81%
BMYBristol-Myers Squibb-1.00-1.77%
LLYEli Lilly and Co-1.64-2.02%
NVONovo Nordisk-0.45-1.00%
Data as of 4:05pm ET, 09/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$3.65
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs